Multicenter phase II study of triple combination with S-1 and cisplatin (CDDP) plus paclitaxel (TXL) in patients with advanced gastric cancer

4539 Background: S-1 plus CDDP is active and tolerable against advanced gastric cancer (AGC) (Iwase H et al., ASCO 2005). The synergistic antitumor effect of TXL and S-1 has been shown in a preclin...